![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Abbott Secures FDA Clearance for Diagnostic Systems
Abbott Secures FDA Clearance for Diagnostic Systems
![abbott-logo.gif](https://www.fdanews.com/ext/resources/test/Drug-Images/abbott-logo.gif?t=1614806228&width=430)
November 2, 2017
Abbott won 510(k) clearance for its Alinity ci-series diagnostic systems for clinical chemistry and immunoassay testing.
The new systems are half the size of existing products and can deliver upwards of 650 tests per hour, the company said.
The Alinity c system for clinical chemistry testing and the Alinity i system for immunoassay testing can be used individually or as a unit.
Upcoming Events
-
21Oct